Fianlimab Antibody
Fianlimab (REGN3767) is a human monoclonal antibody targeting LAG-3, designed for research into cancer immunotherapy. It exhibits antitumor activity and is utilized in preclinical studies, including in vitro assays and in vivo models, to investigate mechanisms and therapeutic potential in melanoma and other cancers.
Product Specifications
Product Name Alternative
Fianlimab, REGN 3767, REGN3767, REGN-3767
Target
LAG-3
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
6.81 mg/mL
Purity
99.04% (May vary between batches)
Molecular Weight
146.46 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6429861-01 0.1 mL
NTRK2 (Neurotrophic Tyrosine Kinase Receptor Type 2, GP145-TrkB, TRKB) (PE)
Sign In for Pricing
View Details MBS6429861-02 5x 0.1 mL
NTRK2 (Neurotrophic Tyrosine Kinase Receptor Type 2, GP145-TrkB, TRKB) (PE)
Sign In for Pricing
View Details 
M2425-01G 200 µg
Matrix Metalloproteinase 9 (Matrix Metallopeptidase 9, MMP-9, MMP9, 92kD Gelatinase, 92kD Type IV Collagenase, CLG4B, Gelatinase B, GELB, MANDP2) discontinued
Sign In for Pricing
View Details